» Articles » PMID: 30792419

Asymmetric Independence Modeling Identifies Novel Gene-environment Interactions

Overview
Journal Sci Rep
Specialty Science
Date 2019 Feb 23
PMID 30792419
Authors
Affiliations
Soon will be listed here.
Abstract

Most genetic or environmental factors work together in determining complex disease risk. Detecting gene-environment interactions may allow us to elucidate novel and targetable molecular mechanisms on how environmental exposures modify genetic effects. Unfortunately, standard logistic regression (LR) assumes a convenient mathematical structure for the null hypothesis that however results in both poor detection power and type 1 error, and is also susceptible to missing factor, imperfect surrogate, and disease heterogeneity confounding effects. Here we describe a new baseline framework, the asymmetric independence model (AIM) in case-control studies, and provide mathematical proofs and simulation studies verifying its validity across a wide range of conditions. We show that AIM mathematically preserves the asymmetric nature of maintaining health versus acquiring a disease, unlike LR, and thus is more powerful and robust to detect synergistic interactions. We present examples from four clinically discrete domains where AIM identified interactions that were previously either inconsistent or recognized with less statistical certainty.

References
1.
Yang Q, Khoury M, Sun F, Flanders W . Case-only design to measure gene-gene interaction. Epidemiology. 1999; 10(2):167-70. View

2.
Martinelli I, Taioli E, Bucciarelli P, Akhavan S, Mannucci P . Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Arterioscler Thromb Vasc Biol. 1999; 19(3):700-3. DOI: 10.1161/01.atv.19.3.700. View

3.
Castellsague X, Munoz N, De Stefani E, Victora C, Castelletto R, Rolon P . Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer. 1999; 82(5):657-64. DOI: 10.1002/(sici)1097-0215(19990827)82:5<657::aid-ijc7>3.0.co;2-c. View

4.
Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen L, Nicolaes G . Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. Lancet. 2000; 354(9195):2036-40. DOI: 10.1016/s0140-6736(99)06092-4. View

5.
Seligsohn U, Lubetsky A . Genetic susceptibility to venous thrombosis. N Engl J Med. 2001; 344(16):1222-31. DOI: 10.1056/NEJM200104193441607. View